reveromycin a has been researched along with B-Cell Lymphoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imajoh-Ohmi, S; Ishikawa, F; Kakiuchi, T; Osada, H; Tanaka, Y; Uchida, T | 1 |
1 other study(ies) available for reveromycin a and B-Cell Lymphoma
| Article | Year |
|---|---|
Reveromycin A inhibits antigen receptor-mediated antigen presentation by B lymphoma cells via its effect on intracellular trafficking of the antigen.
Topics: Flow Cytometry; Lymphoma, B-Cell; Pyrans; Receptors, Antigen, B-Cell; Spiro Compounds; Tumor Cells, Cultured | 2002 |